Valneva to cut up to 15% of jobs as reduced travel hits vaccine demand

French vaccine maker Valneva is laying off 10% to 15% of its workforce and reducing revenue projections due to "an emerging adverse trend in travel vaccine uptake across key markets." The drugmaker